HCM
BMY icon

Herndon Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Herndon Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-154
Closed -$8K – 259
2016
Q3 		$8K Hold
154
– – ﹤0.01% 185
2016
Q2 		$11K Buy
+154
New +$10.9K ﹤0.01% 183

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Herndon Capital Management's BMY Position: Q4 2016 in Review

Herndon Capital Management sold out of Bristol-Myers Squibb (BMY) in Q4 2016, closing a stake of 154 shares — an estimated $8K sold.

Herndon Capital Management first reported a position in BMY in Q2 2016 and held it in 2 quarters. The position peaked at $11K in Q2 2016. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

  • Herndon Capital Management reported no remaining Bristol-Myers Squibb position as of Q4 2016 after selling out during the quarter.
  • Herndon Capital Management sold 154 Bristol-Myers Squibb shares in Q4 2016, an estimated $8K.
  • Herndon Capital Management first reported a position in Bristol-Myers Squibb in Q2 2016 and held it in 2 quarters.
  • Herndon Capital Management's Bristol-Myers Squibb position peaked at $11K in Q2 2016.
  • 1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on Herndon Capital Management's 13F filing for Q4 2016, filed 2 Feb 2017.